These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 9272485

  • 1. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
    Tarazi FI, Yeghiayan SK, Baldessarini RJ, Kula NS, Neumeyer JL.
    Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
    [Abstract] [Full Text] [Related]

  • 2. Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs.
    Tarazi FI, Yeghiayan SK, Neumeyer JL, Baldessarini RJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):693-707. PubMed ID: 9682281
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.
    J Neurosci Res; 2006 Aug 15; 84(3):675-82. PubMed ID: 16810690
    [Abstract] [Full Text] [Related]

  • 5. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 6. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 15; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 7. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1998 Jul 15; 124(5):889-96. PubMed ID: 9692773
    [Abstract] [Full Text] [Related]

  • 8. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
    Tarazi FI, Campbell A, Baldessarini RJ.
    Neuroscience; 1998 Nov 15; 87(1):1-4. PubMed ID: 9722137
    [Abstract] [Full Text] [Related]

  • 9. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb 15; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 10. Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects.
    Moran-Gates T, Gan L, Park YS, Zhang K, Baldessarini RJ, Tarazi FI.
    Synapse; 2006 Feb 15; 59(2):92-100. PubMed ID: 16270300
    [Abstract] [Full Text] [Related]

  • 11. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 15; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 12. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
    Assié MB, Consul-Denjean N, Koek W, Newman-Tancredi A.
    Pharmacology; 2005 Oct 15; 75(2):63-8. PubMed ID: 16020947
    [Abstract] [Full Text] [Related]

  • 13. Regional distribution of dopamine D4 receptors in rat forebrain.
    Tarazi FI, Kula NS, Baldessarini RJ.
    Neuroreport; 1997 Nov 10; 8(16):3423-6. PubMed ID: 9427299
    [Abstract] [Full Text] [Related]

  • 14. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA, Piercey MF.
    J Neural Transm (Vienna); 1998 Nov 10; 105(6-7):749-67. PubMed ID: 9826116
    [Abstract] [Full Text] [Related]

  • 15. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 10; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
    Hillefors M, von Euler G.
    Neurochem Int; 2001 Jan 10; 38(1):31-42. PubMed ID: 10913686
    [Abstract] [Full Text] [Related]

  • 17. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ.
    Neuroscience; 1998 Mar 10; 83(1):169-76. PubMed ID: 9466407
    [Abstract] [Full Text] [Related]

  • 18. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 19. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA, DiCarlo JJ, Zhang Y, Thompson P, Meltzer HY.
    J Pharmacol Exp Ther; 1993 Sep 27; 266(3):1374-84. PubMed ID: 8103793
    [Abstract] [Full Text] [Related]

  • 20. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS, Goldman-Rakic PS.
    J Pharmacol Exp Ther; 1997 Nov 27; 283(2):939-46. PubMed ID: 9353417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.